• Setting a
    New Standard

    Vazculep® is the only FDA-approved
    Phenylephrine HCl Injection available in
    all 3 vial sizes – 1 mL, 5 mL and 10 mL

    Complete Range of
    3 Vial Sizes!

    Vazculep®
    Reach for the New Standard!



INDICATIONS AND USAGE
VAZCULEP® (phenylephrine hydrochloride) Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS
None

WARNINGS AND PRECAUTIONS
Extravasation during intravenous administration may cause necrosis or sloughing of tissue
Severe bradycardia and decreased cardiac output
Allergic-type reactions: Sulfite
Concomitant use with oxytocic drugs: Pressor effect of sympathomimetic pressor amines is potentiated

ADVERSE REACTIONS
Most common adverse reactions during treatment: nausea, vomiting, and headache.

To report SUSPECTED ADVERSE REACTIONS, contact Éclat Pharmaceuticals at 1-877-622-2320 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch
.

Please see the accompanying full prescribing information for complete safety information and dosage and administration instructions.